Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on MT-8554 assessing safety, tolerability, and pharmacokinetics with multiple doses in women with vasomotor symptoms, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• MT-8554

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Vasomotor Symptoms | Phase 1 | Status: COMPLETED